{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T11:35:14Z","timestamp":1781955314733,"version":"3.54.5"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ijcard.2013.11.048","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T03:02:27Z","timestamp":1385434947000},"page":"286-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Ischemic heart disease in systemic inflammatory diseases. An appraisal"],"prefix":"10.1016","volume":"170","author":[{"given":"Paola","family":"Gargiulo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Marsico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Parente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Paolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Cecere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Casaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Maria","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Formisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Fabiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Soricelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Trimarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Perrone-Filardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2013.11.048_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0010","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.autrev.2007.01.009","article-title":"The laboratory approach to the diagnosis of autoimmune diseases: is it time to change?","volume":"6","author":"Villalta","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cjca.2010.12.040","article-title":"Chronic inflammatory diseases and cardiovascular risk: a systematic review","volume":"27","author":"Roifman","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.coi.2007.11.001","article-title":"Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association","volume":"19","author":"McMahon","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.autrev.2005.08.008","article-title":"Premature atherosclerotic disease in systemic lupus erythematosus\u2014role of inflammatory mechanisms","volume":"5","author":"Rhew","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ncprheum0092","article-title":"Mechanisms of disease: atherosclerosis in autoimmune diseases","volume":"2","author":"Sherer","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"37","author":"Wolfe","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0040","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial dysfunction: a marker of atherosclerotic risk","volume":"23","author":"Bonetti","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0045","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0050","doi-asserted-by":"crossref","first-page":"R984","DOI":"10.1186\/ar1775","article-title":"Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study","volume":"7","author":"Warrington","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0055","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jbspin.2010.07.016","article-title":"Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis","volume":"78","author":"Boyer","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/157016110791112269","article-title":"Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors","volume":"8","author":"Toms","year":"2010","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0070","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1136\/ard.2009.126128","article-title":"Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the apolipoprotein-related mortality risk (amoris) study","volume":"69","author":"Semb","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaut.2007.02.004","article-title":"The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia","volume":"28","author":"Hahn","year":"2007","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0080","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/ard.2010.142133","article-title":"Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives","volume":"70","author":"Kitas","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0090","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/archinte.165.14.1624","article-title":"Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation","volume":"165","author":"Escalante","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0095","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1002\/art.20612","article-title":"Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis","volume":"50","author":"Kremers","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0100","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/art.1780390504","article-title":"Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins","volume":"39","author":"Silman","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0105","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/rheumatology\/ker258","article-title":"Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis","volume":"50","author":"Bergstrom","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/ard.56.8.463","article-title":"Cigarette smoking and rheumatoid arthritis severity","volume":"56","author":"Saag","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0115","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s10067-011-1775-5","article-title":"Current smoking status is associated to a non-ACR 50 response in early rheumatoid arthritis. A cohort study","volume":"30","author":"Rojas-Serrano","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.smim.2011.01.014","article-title":"Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis","volume":"23","author":"Klareskog","year":"2011","journal-title":"Semin Immunol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"Eular evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0130","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","article-title":"Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis","volume":"107","author":"Solomon","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0135","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/01.ATV.18.5.768","article-title":"Plasma viscosity and the risk of coronary heart disease: results from the Monica\u2013Augsburg cohort study, 1984 to 1992","volume":"18","author":"Koenig","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0140","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.atherosclerosis.2011.08.026","article-title":"Hemorheological parameters are related to subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis patients","volume":"219","author":"Santos","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0145","first-page":"2562","article-title":"Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset","volume":"26","author":"Wallberg-Jonsson","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0150","first-page":"1997","article-title":"Relationship between brachial artery flow-mediated dilation and coronary flow reserve in patients with peripheral artery disease","volume":"46","author":"Pellegrino","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0155","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.amjcard.2005.06.084","article-title":"Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease","volume":"96","author":"Perrone-Filardi","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0160","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/euhj.2001.2965","article-title":"Carotid intima\u2013media thickness at different sites: relation to incident myocardial infarction; the Rotterdam Study","volume":"23","author":"Iglesias del Sol","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199901073400103","article-title":"Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group","volume":"340","author":"O'Leary","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0170","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0175","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/art.10269","article-title":"Increased thickness of the arterial intima\u2013media detected by ultrasonography in patients with rheumatoid arthritis","volume":"46","author":"Kumeda","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0180","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.atherosclerosis.2007.11.013","article-title":"Impaired coronary microvascular function and increased intima\u2013media thickness in rheumatoid arthritis","volume":"198","author":"Ciftci","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0185","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/eurheartj\/ehq235","volume":"32","author":"Perrone-Filardi","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1440-1797.2005.00392.x","article-title":"Pathogenesis of lupus nephritis: an update","volume":"10","author":"Tang","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0195","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.56.7.481","article-title":"Pathogenesis of systemic lupus erythematosus","volume":"56","author":"Mok","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0200","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","article-title":"The bimodal mortality pattern of systemic lupus erythematosus","volume":"60","author":"Urowitz","year":"1976","journal-title":"Am J Med"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0205","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa035611","article-title":"Premature coronary-artery atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Asanuma","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0210","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9343(92)90578-Y","article-title":"Risk factors for coronary artery disease in patients with systemic lupus erythematosus","volume":"93","author":"Petri","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0215","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1468-3083.2011.04211.x","article-title":"Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients","volume":"26","author":"Yang","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0220","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.CIR.0000136807.78534.50","article-title":"Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women","volume":"110","author":"El-Magadmi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0225","doi-asserted-by":"crossref","first-page":"R186","DOI":"10.1186\/ar2878","article-title":"Predictors of the first cardiovascular event in patients with systemic lupus erythematosus\u2014a prospective cohort study","volume":"11","author":"Gustafsson","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0230","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1191\/0961203305lu2157oa","article-title":"High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk","volume":"14","author":"Barnes","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0235","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1191\/0961203303lu1024oa","article-title":"Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention","volume":"13","author":"Aringer","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0240","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMp038168","article-title":"Systemic lupus erythematosus and accelerated atherosclerosis","volume":"349","author":"Hahn","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0245","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/art.20432","article-title":"Platelet-activating factor-acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus","volume":"50","author":"Cederholm","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0250","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/hc4101.097518","article-title":"Risk factors for cardiovascular disease in systemic lupus erythematosus","volume":"104","author":"Svenungsson","year":"2001","journal-title":"Circulation"},{"issue":"Suppl. 5","key":"10.1016\/j.ijcard.2013.11.048_bb0255","doi-asserted-by":"crossref","first-page":"v16","DOI":"10.1093\/rheumatology\/ken280","article-title":"Macrovascular disease in systemic sclerosis: the tip of an iceberg?","volume":"47","author":"Belch","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0260","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0002-9343(74)90008-4","article-title":"Pericardial disease in scleroderma (systemic sclerosis)","volume":"57","author":"JEt","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0265","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM198401193100302","article-title":"Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma","volume":"310","author":"Follansbee","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0270","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls","volume":"46","author":"D'Angelo","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0275","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/art.23540","article-title":"A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls","volume":"59","author":"Khurma","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0280","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/sarh.2002.50011","article-title":"Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis","volume":"32","author":"Cerinic","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0285","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/08916939908994064","article-title":"Autoimmunity and vascular involvement in systemic sclerosis (ssc)","volume":"31","author":"Kahaleh","year":"1999","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0290","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/rheumatology\/kel426","article-title":"Endothelial dysfunction precedes atherosclerosis in systemic sclerosis\u2014relevance for prevention of vascular complications","volume":"46","author":"Szucs","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0295","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr218","article-title":"ESC guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology (ESC)","volume":"32","author":"Regitz-Zagrosek","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0300","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00296-004-0580-8","article-title":"Lipoprotein profile in limited systemic sclerosis","volume":"25","author":"Borba","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0305","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijcard.2006.08.119","article-title":"Myocardial and vascular dysfunction in systemic sclerosis: the potential role of noninvasive assessment in asymptomatic patients","volume":"121","author":"D'Andrea","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0310","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/rheumatology\/kel076","article-title":"Circulating levels of nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis","volume":"46","author":"Kaloudi","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0315","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-8703(98)70137-1","article-title":"Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon","volume":"136","author":"Lekakis","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0320","doi-asserted-by":"crossref","first-page":"501","DOI":"10.5694\/j.1326-5377.2006.tb00665.x","article-title":"Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic review","volume":"185","author":"Schaffer","year":"2006","journal-title":"Med J Aust"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0325","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/ard.2006.068650","article-title":"Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials","volume":"66","author":"Scott","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0330","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2012-eular.2572","article-title":"Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study","author":"Lindhardsen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0335","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/rheumatology\/kep096","article-title":"Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis","volume":"48","author":"Ravindran","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0340","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/rheumatology\/kei031","article-title":"A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal","volume":"44","author":"Choy","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0345","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1186\/ar3868","article-title":"Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals","volume":"14","author":"Mercer","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0350","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1177\/0961203312450084","article-title":"Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect","volume":"21","author":"Cairoli","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0355","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/rheumatology\/kep366","article-title":"The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review","volume":"49","author":"Westlake","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0360","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.healun.2005.02.002","article-title":"Mycophenolate Mofetil Cardiac Study I. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients","volume":"24","author":"Eisen","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0365","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1007\/s00296-011-2048-y","article-title":"Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2years","volume":"32","author":"Kiani","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0370","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/03009740802363768","article-title":"Sustained improvement of vascular endothelial function during anti-tnfalpha treatment in rheumatoid arthritis patients","volume":"38","author":"Sidiropoulos","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0375","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/ard.2004.026534","article-title":"Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"64","author":"Kiortsis","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0380","first-page":"2102","article-title":"Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis","volume":"32","author":"Mac\u00edas","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0385","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/art.20407","article-title":"Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody","volume":"51","author":"Gonzalez-Juanatey","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0390","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2004.04.031","article-title":"Effect of anti tnfalpha therapy on arterial diameter and wall shear stress and HDL cholesterol","volume":"177","author":"Irace","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0395","first-page":"864","article-title":"Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials","volume":"306","author":"Ryan","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0400","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/2047487312450228","volume":"19","author":"Fifth Joint Task Force of the European Society of C","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ijcard.2013.11.048_bb0405","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313020664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313020664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T17:16:05Z","timestamp":1597079765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527313020664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0167527313020664"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.11.048","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ischemic heart disease in systemic inflammatory diseases. An appraisal","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.11.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}